Biogen to acquire RayThera for up to $1 billion
Biogen Inc. (Nasdaq: BIIB) has entered into a definitive agreement to acquire RayThera Inc., a private San Diego-based biotechnology company ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
